Cube Labs

Cube Labs

Servizi di ricerca

Rome, Latium 2.727 follower

We enable innovation.

Chi siamo

Cube Labs is an Italian venture builder in the healthcare technology sector created to bridge the gap between excellent academic science and the commercial Life Science market. Cube Labs creates new companies based on promising R&D activities and promotes innovation to transform pioneering science into healthcare solutions. Cube Labs’ mission is to translate scientific research into impactful, real-world solutions while spearheading the democratization of life sciences for a healthier, more inclusive world where all individuals can benefit from innovation. In March 2023, it was listed on the Milan Stock Exchange, validating its vision and attracting growing interest in healthcare tech innovation.

Sito Web
http://www.cube-labs.com
Settore
Servizi di ricerca
Dimensioni dell’azienda
11-50 dipendenti
Sede principale
Rome, Latium
Tipo
Società privata non quotata
Settori di competenza
startup, academic spinoff, healthcare, Life Science, Nutraceuticals, Innovation, MedTech e Therapeutics

Località

Dipendenti presso Cube Labs

Aggiornamenti

  • Visualizza la pagina dell’organizzazione di Cube Labs, immagine

    2.727 follower

    🚀 Exciting News We are honored to announce that Cube Labs has been nominated for the 𝟐𝟎𝟐𝟒 𝐏𝐫𝐢𝐱 𝐆𝐚𝐥𝐢𝐞𝐧 𝐔𝐒𝐀 in the 𝑰𝒏𝒄𝒖𝒃𝒂𝒕𝒐𝒓𝒔, 𝑨𝒄𝒄𝒆𝒍𝒆𝒓𝒂𝒕𝒐𝒓𝒔, 𝑬𝒒𝒖𝒊𝒕𝒚 category! This prestigious recognition celebrates global leaders driving #innovation in life sciences, and we are proud to be considered alongside other groundbreaking organizations. The Prix Galien, often referred to as the "Nobel Prize for Life Sciences," is the highest tribute for excellence in research and development in #healthcare. This nomination is a testament to our commitment to transforming cutting-edge scientific discoveries into #impactful healthcare solutions and fostering a healthier, more inclusive world. Thank you to everyone who continues to support our mission! Learn more about the announcement here: https://lnkd.in/dBMUXMBp https://lnkd.in/ev2cTc29

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Cube Labs, immagine

    2.727 follower

    𝗢𝗿𝗽𝗵𝗮 𝗕𝗶𝗼𝘁𝗲𝗰𝗵, a spin-off of the portfolio of Cube Labs, dedicated to the discovery of new medical solutions for rare diseases, has broadened the expertise of its team by onboarding Andrei Paraschiv, PhD student graduated in Chemistry and Pharmaceutical Technologies. His solid background and expertise in chemistry will support the team in developing innovative solutions and optimizing processes.   Last week, Andrei presented a poster on a novel #sustainable protocol for fine chemical synthesis at the XXVIII National Congress of Società Chimica Italiana in Milan. Andrei introduced an innovative way to make #chemical reactions faster and greener, which could have big benefits for industries like pharmaceuticals. The research focuses on using a special copper-based catalyst to perform what's called "C-H amination" in heterogenous phase, an important process for creating various valuable heterocyclic compounds, without needing any extra additives like acids or bases.

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Cube Labs, immagine

    2.727 follower

    🚀We are thrilled to announce that our spin-offs, 𝗔𝗱𝗮𝗺𝗮𝘀 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 and 𝗗𝗧𝗲𝗰𝗵, have been selected for funding by the NBFC - National Biodiversity Future Center! As the first national center in Italy focused on #biodiversity, the NBFC—coordinated by Consiglio Nazionale delle Ricerche—plays a crucial role in promoting innovation and research in #sustainability and environmental protection. This prestigious recognition highlights our commitment to sustainable and #impactful innovation, reinforcing our dedication to advancing scientific research in the #LifeScience sector. A big congratulations to Adamas and DTech teams involved in this achievement! We look forward to continuing our journey of driving positive change and fostering a sustainable future. 👉Discover more: https://lnkd.in/diQ6ydbD

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Cube Labs, immagine

    2.727 follower

    𝗖𝘂𝗯𝗲 𝗟𝗮𝗯𝘀 𝗶𝘀 𝘁𝗵𝗿𝗶𝗹𝗹𝗲𝗱 𝘁𝗼 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲 𝘁𝗵𝗲 𝗹𝗮𝘂𝗻𝗰𝗵 𝗼𝗳 𝘁𝗵𝗲 𝗦𝗲𝗰𝗼𝗻𝗱 𝗘𝗱𝗶𝘁𝗶𝗼𝗻 𝗼𝗳 𝗖𝗮𝗹𝗹 𝗳𝗼𝗿 𝗜𝗺𝗽𝗮𝗰𝘁𝗳𝘂𝗹 𝗩𝗲𝗻𝘁𝘂𝗿𝗲𝘀 🚀 Following the success of our first edition, we are once again inviting #LifeScience innovators, #startups, and visionary entrepreneurs to take part in this transformative journey within Cube Labs' #VentureBuilding environment. Selected participants will benefit from robust support, including pre-seed #investment and comprehensive guidance from our expert team – covering legal, regulatory, clinical trials, and beyond. If you're ready to turn your groundbreaking ideas into reality, we want to hear from you! 👉Discover more and apply here: https://lnkd.in/dQBngzTB

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Cube Labs, immagine

    2.727 follower

    🔬 Exciting News from 𝐂𝐚𝐫𝐭𝐢𝐥𝐚𝐠𝐨! We are thrilled to announce that Cartilago, our innovative #regenerative medicine startup, has received a Notice of Allowance for its second US patent. This groundbreaking patent encompasses injectable therapies targeting #osteoarthritis and related conditions, marking a significant milestone in our mission to deliver innovative #healthcare solutions. Onward to transforming patient care! Discover more: https://lnkd.in/gv2pSXWa

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Cube Labs, immagine

    2.727 follower

    🎉 We are excited to announce that 𝐑𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐛𝐢𝐨𝐦𝐚 is one of the winners of the Call 4 Ideas FVG! Cluster Scienze della Vita del Friuli Venezia Giulia has recognized the top 11 innovative ideas in the #LifeSciences, and our startup is honored to be among them. With a €10,000 award and the potential for additional funding, we are eager to turn our vision into reality, developing our combined medical device for the treatment of chronic wounds. We also extend our heartfelt congratulations to the other winning teams for their outstanding contributions to the future of medical research and improving human life quality. #Innovation #LifeScience #Startup #Call4Ideas #FriuliVeneziaGiulia

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Cube Labs, immagine

    2.727 follower

    🗓️ Mid & Small | Virtual 2024 organizzata da Virgilio ir prende il via lunedì 1 luglio. L'evento è dedicato alle società quotate Mid & Small Cap e Cube Labs non poteva mancare. La partecipazione a Mid & Small rappresenta un'opportunità fondamentale per continuare ad ampliare la rete di contatti e le possibilità di accedere a nuove risorse per continuare a crescere.

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Cube Labs, immagine

    2.727 follower

    🚀 Cube Labs è stata selezionata dall’Osservatorio Startup Hi-tech tra le realtà italiane più significative del 2023, nella categoria #TopExit, nell’ambito dell’annuale ricerca sul panorama imprenditoriale italiano. Il report presenta i risultati relativi alla ricerca annuale dell’Osservatorio Startup Hi-tech, promosso dalla School of Management del Politecnico di Milano, circa la quantificazione degli investimenti in #startup hi-tech in Italia da parte di attori formali, informali e internazionali e all’analisi di una selezione di startup significative in termini di round di finanziamento, fatturato ed exit. Scopri di più: https://lnkd.in/dNgeJ-K8 Osservatori Digital Innovation

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Cube Labs, immagine

    2.727 follower

    We are thrilled to share highlights from Cube Labs participation in the prestigious 𝐏𝐫𝐢𝐱 𝐆𝐚𝐥𝐢𝐞𝐧 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥, where we hosted the panel 𝑩𝒆𝒚𝒐𝒏𝒅 𝑩𝒐𝒓𝒅𝒆𝒓𝒔: 𝑰𝒏𝒊𝒕𝒊𝒂𝒕𝒊𝒗𝒆𝒔 𝒇𝒐𝒓 𝑫𝒆𝒎𝒐𝒄𝒓𝒂𝒕𝒊𝒛𝒊𝒏𝒈 𝑳𝒊𝒇𝒆 𝑺𝒄𝒊𝒆𝒏𝒄𝒆 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒊𝒆𝒔 𝒂𝒏𝒅 𝑷𝒓𝒐𝒎𝒐𝒕𝒊𝒏𝒈 𝑨𝒄𝒄𝒆𝒔𝒔 𝒕𝒐 𝑯𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆. During the last panel, our CEO, Filippo Surace, engaged in a discussion on the ethical challenges facing our sector, emphasizing the importance of equitable healthcare access. The event culminated in Awards Ceremony, celebrating groundbreaking scientific advancements on a global stage. A heartfelt thank you to all participants and organizers for an inspiring and impactful event! #PrixGalien #HealthcareInnovation #HealthcareAccess #Ethics

    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione di Cube Labs, immagine

    2.727 follower

    🔬Panel Discussion: 𝐁𝐞𝐲𝐨𝐧𝐝 𝐁𝐨𝐫𝐝𝐞𝐫𝐬: 𝐈𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐯𝐞𝐬 𝐟𝐨𝐫 𝐃𝐞𝐦𝐨𝐜𝐫𝐚𝐭𝐢𝐳𝐢𝐧𝐠 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐚𝐧𝐝 𝐏𝐫𝐨𝐦𝐨𝐭𝐢𝐧𝐠 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 Join Cube Labs’ panel at Prix Galien International focusing on the global imperative of democratizing life science technologies and enhancing access to healthcare for all. Our esteemed panelists will share insights and explore practical solutions to bridge the gap in healthcare access across borders. Register now and join us in making a difference: 👉 https://lnkd.in/g9uAyhtH The Galien Foundation #PrixGalien #GlobalHealth #HealthcareAccess #Democratization

    Visualizza la pagina dell’organizzazione di The Galien Foundation, immagine

    6.934 follower

    Join us for an exclusive panel discussion on global initiatives for democratizing life science technologies and promoting access to healthcare! 🌍🔬 We are thrilled to announce a distinguished panel for the Prix Galien International event, featuring some of the world's leading experts in healthcare innovation and access: Panel Topic: BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE Panel Chair: 🔸 Dr. Filippo Surace - Serial Entrepreneur, Surgeon, Inventor, Founder and CEO of Cube Labs, CEO of Gruppo Surace. Moderator: 🔸 Dr. Işıl Güney - Molecular Biologist, Partner at Bioscience Managers Pty Ltd, Partner and Co-founder of The Ulysses Advisory Group. Panelists: 🔸 Yossi Bornstein - CEO and Founder of Shizim Group, Founder of Israel Life Science Industry Organization, Founder of Israel Tech Transfer Organization, Former CEO of Bristol Myers Squibb. 🔸 Dr. Chris Hentschel - Molecular Biologist, Former CEO of Medicines for Malaria Venture, Former CEO of MRC Collaborative Center, Former CSO of Centocor. 🔸 Mario Marazziti - Italian Politician and Journalist, Member of Italian Parliament, Human Rights Leader, Health Diplomacy Leader, Community of Sant’Egidio. 🔸 Satish Modi - Chairman of Modi Global Enterprises, Chairman of Gujar Mal Modi Science Foundation, Philanthropist, Author. 🔸 Wee Meng Thoo - Senior Partner of Asian Family Offices, Healthcare and Pharma ESG investor, Global PE/VC investor, Former Executive at Oracle and HP. This event promises to deliver valuable insights into the latest global efforts to democratize life science technologies and enhance healthcare access worldwide. Don't miss the opportunity to hear from these esteemed professionals and engage in this vital discussion. 🔗 Register now: https://lnkd.in/g9uAyhtH 📢 Spread the word and stay tuned for more updates! #PrixGalien #GlobalHealth #LifeScienceTechnologies #HealthcareAccess #MedicalAdvancements #GalienFoundation

Pagine affiliate

Pagine simili

Sfoglia le offerte di lavoro